Johnson & Johnson to Host Pharmaceuticals Business Review
NEW BRUNSWICK, N.J., April 23, 2013
NEW BRUNSWICK, N.J., April 23, 2013 /PRNewswire/ --Johnson & Johnson (NYSE:
JNJ) will host a review of its Pharmaceuticals business for the Investment
Community beginning at 8:30 a.m. (Eastern Time) on Thursday, May 23, 2013 at
the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at
approximately 3:00 p.m.
Paul Stoffels, M.D., Worldwide Chairman Pharmaceuticals, and Chief Scientific
Officer and Joaquin Duato, Worldwide Chairman, Pharmaceuticals will host the
meeting. The meeting will also feature presentations from the therapeutic area
leaders within the Pharmaceuticals Research and Development organization.
The agenda for the day will be posted on the Investor Relations website on
approximately May 16th.
Investors and other interested parties may access this meeting by visiting the
Company's website at www.investor.jnj.com for a simultaneous webcast of the
A replay and podcast will be available shortly after the live webcast through
SOURCE Johnson & Johnson
Contact: Press - Ernie Knewitz, (732) 524-6623, (917) 697-2318 (M), or Al
Wasilewski, (732) 524-1130, (732) 447-5918 (M), or Investors - Louise
Mehrotra, (732) 524-6491, or Stan Panasewicz, (732) 524-2524
Press spacebar to pause and continue. Press esc to stop.